These antigen presenting fibroblasts show up-regulated interferon-gamma (IFNγ) responses and JAK-STAT pathway activation, but they also seem to exert a regulatory action in DCM-associated HF, communicating via anti-inflammatory ligand–receptor interactions with CD4+ T cells. The gene discussed is IFNG; the disease is familial dilated cardiomyopathy.